Multiple effects of theobromine on fetus development and postnatal status of the immune system

International Journal of Tissue Reactions

Volumn 26, Issue 1-2, 2004, Pages 53-60

  Chorostowska Wynimko, Joanna ^a   Skopinska Rozewska E ^a   Sommer, E ^a   Rogala, E ^a   Skopinski P ^b   Wojtasik, E ^c  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Office for Medicinal Products   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

THEOBROMINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; FETUS DEVELOPMENT; FETUS WEIGHT; FUNCTIONAL ASSESSMENT; GRAFT VERSUS HOST REACTION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INTRAUTERINE GROWTH RETARDATION; MOUSE; MOUSE STRAIN; NONHUMAN; PERINATAL DRUG EXPOSURE; POSTNATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; SPLENOMEGALY; TISSUE DISTRIBUTION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, NEWBORN; FEMALE; FETUS; IMMUNE SYSTEM; LACTATION; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; THEOBROMINE; VASODILATOR AGENTS;

EID: 8844287593     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gilbert J., Scott P. Food additives and contaminants started in 1984. Food Addit. Contam., 17(1), 1, 2000.
2. Nawrot P., Jordan S., Eastwood J., et al. Effects of caffeine on human health. Food Addit. Contam., 20(1), 1, 2003.
3. Wilkinson J.M., Pollard I. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res, Dev. Brain Res., 75(2), 193, 1993.
4. Abdi F., Pollard I., Wilkinson J. Placental transfer and foetal disposition of caffeine and its immediate metabolites in the 20-day pregnant rat: function of dose. Xenobiotica, 23(4), 449, 1993.
5. Atkinson H.C., Begg E.J., Darlow B.A. Drugs in human milk. Clinical pharmacokinetic considerations. Clin. Pharmacokinet., 4 217, 1998.
6. Patole S., Vijayakumar P., Jog S. Perinatal immunomodulation. J. Matern. Fetal Neonatal Med., 11(5), 290, 2002.
7. Fortier I., Marcoux S., Beaulac-Baillargeon L. Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. Am. J. Epidemiol., 137(9), 931, 1993.
8. Cook D.G., Peacock J.L., Feyerabend C., et al. Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: Prospective population based study. BMJ, 313, 1358, 1996.
9. Matsuoka R., Uno H., Tanaka H., et al. Caffeine induces cardiac and other malformations in the rat. Am. J. Med. Genet. Suppl., 3, 433, 1987.
10. Pollard I., Locquet O., Solvar A., Magre S. Effects of caffeine and its reactive metabolites theophylline and theobromine on the differentiating testis. Reprod. Fertil. Dev., 13(5-6), 435, 2001.
11. Tarka S.M. Jr., Applebaum R.S., Borzelleca J.F. Evaluation of the perinatal, postnatal and teratogenic effects of cocoa powder and theobromine in Sprague-Dawley/CD rats. Food Chem. Toxicol., 24 5), 375, 1986.
12. Tarka S.M. Jr., Applebaum R.S., Borzelleca J.F. Evaluation of the teratogenic potential of cocoa powder and theobromine in New Zealand White rabbits. Food Chem. Toxicol., 24(5), 363, 1986.
13. Skopinska-Rozewska E., Janik P., Przbyszewska M., et al. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29 Int. J. Mol. Med, 2(6), 649, 1998.
14. Barcz E., Sommer E., Sokolnicka I., et al. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. Oncol. Rep., 5(2), 517, 1998.
15. Skopinska-Rozewska E., Krotkiewski M., Sommer E., et al. Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumour cells. Oncol. Rep., 6(6), 1341, 1999.
16. Kiminski P., Skopinska-Rozewska E., Bany J., et al. The effect of salbutamol treatment on the cellular immunity of the offspring ofpregnant mice: spleen cell activity. Drugs Exptl. Clin. Res., 24 77, 1998.
17. Sidky Y., Auerbach R. Lymphocyte-induced angiogenesis, a quantitative and sensitive assay of the graft-versus-host reaction. J. Exp. Med., 141, 1081, 1975.
18. Chorostowska-Wynimko J., Krotkiewski M., Radomska-Lesniewska D., et al. The synergistic effect of lactic acid bacteria and alkylglycerols on the humoral immunity in mice. Int. J. Tissue React., 23, 81, 2001.
19. Kaminski P., Skopinska-Rozewska E., Wasik M., et al. Granulocyte chmiluminescent activity, antiboyd production and percentage of CD4(+) and CD8(+) lymphocytes in peripheral blood of offspring of salbutomol-treated pregnant C3H mice. Pharmacol. Res., 41, 89, 2000.
20. York R.G., O'Flaherty E.J., Scott W.J. Jr., Shukla R. Alteration of effective exposure of dam and embryo to caffeine and its metabolites by treatment of mice with beta-naphthoflavone. Toxicol. Appl. Pharmacol., 88(2), 282, 1987.
21. Harper J., Kalgsbrun M. Cartilage to bone - angiogenesis leads the way. Nat. Med., 5(6), 617, 1999.
22. Barcz E., Sommer E., Janik P., et al. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncol. Rep., 7(6), 1285, 2000.
23. Rivkees S.A., Zhao Z., Porter G., Turner C. Influences of adenosine on the fetus and newborn. Mol. Genet. Metab., 74(1-2), 160, 2001.
24. Chorostowska-Wynimko J., Skopinska-Rozewska E., Sommer E., et al. Some immunotropic effects of theophylline and theobromine. Eur Respir J. 8(Suppl. 19), P0315, 1995.
25. Skopinski P., Skopinska-Rozewska E., Sommer E., et al. Chocolate feeding of pregnant mice influences length of limbs of their progeny. Pol. J. Vet. Scie., 6(3 Suppl.), 57, 2003.
26. McNamara P.J., Burgio D., Yoo S.D. Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios. Drug Metab. Dispos., 20(2), 302, 1992.
27. Rosenthal L.A., Taub D.D., Moors M.A., Blank K.J. Methylxanthine-induced inhibition of the antigen- and superantigen specific activation of T and B lymphocytes. Immunopharmacology, 24 3), 203, 1992.
28. Ritter M., Menon S., Zhao L., et al. Functional importance and caffeine sensitivity of ryanodine receptors in primary lymphocytes Int. Immunopharmacol., 1(2), 339, 2001.
29. Rhoem N.W., Sidky Y.A., Auerbach R. Lyt phenotype analysis of the effector cells for evoking lymphocyte-induced angiogenesis (LIA Cell. Immunol., 63, 272, 1981.
30. Sei Y., Gallagher K.L., Daly J.W. Multiple effects of caffeine on Ca2+ release and influx in human B lymphocytes. Cell Calcium, 149, 160, 2001.
31. Conlay L.A., Conant J.A., deBros F., Wurtman R. Caffeine alters plasma adenosine levels. Nature, 389, 136, 1997.
32. Leon D., Albasanz J.L., Ruiz M.A., et al. Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J. Neurochem., 82, 625, 2002.